ABBV vs. ABT
Compare and contrast key facts about AbbVie Inc. (ABBV) and Abbott Laboratories (ABT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ABBV or ABT.
Correlation
The correlation between ABBV and ABT is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ABBV vs. ABT - Performance Comparison
Key characteristics
ABBV:
0.73
ABT:
1.48
ABBV:
0.99
ABT:
2.09
ABBV:
1.15
ABT:
1.27
ABBV:
0.88
ABT:
1.15
ABBV:
2.15
ABT:
7.00
ABBV:
8.44%
ABT:
4.20%
ABBV:
27.49%
ABT:
20.59%
ABBV:
-45.09%
ABT:
-45.66%
ABBV:
-13.55%
ABT:
-3.99%
Fundamentals
ABBV:
$351.09B
ABT:
$230.70B
ABBV:
$2.34
ABT:
$7.70
ABBV:
84.82
ABT:
17.22
ABBV:
0.42
ABT:
4.17
ABBV:
6.05
ABT:
5.33
ABBV:
105.59
ABT:
4.69
ABBV:
$57.37B
ABT:
$42.34B
ABBV:
$44.44B
ABT:
$23.67B
ABBV:
$16.33B
ABT:
$11.20B
Returns By Period
In the year-to-date period, ABBV achieves a 6.39% return, which is significantly lower than ABT's 19.64% return. Over the past 10 years, ABBV has outperformed ABT with an annualized return of 15.79%, while ABT has yielded a comparatively lower 13.13% annualized return.
ABBV
6.39%
6.62%
-5.71%
19.87%
22.17%
15.79%
ABT
19.64%
8.61%
17.37%
30.26%
9.37%
13.13%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ABBV vs. ABT — Risk-Adjusted Performance Rank
ABBV
ABT
ABBV vs. ABT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ABBV vs. ABT - Dividend Comparison
ABBV's dividend yield for the trailing twelve months is around 3.44%, more than ABT's 1.70% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 3.44% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
ABT Abbott Laboratories | 1.70% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% |
Drawdowns
ABBV vs. ABT - Drawdown Comparison
The maximum ABBV drawdown since its inception was -45.09%, roughly equal to the maximum ABT drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for ABBV and ABT. For additional features, visit the drawdowns tool.
Volatility
ABBV vs. ABT - Volatility Comparison
AbbVie Inc. (ABBV) has a higher volatility of 10.10% compared to Abbott Laboratories (ABT) at 5.53%. This indicates that ABBV's price experiences larger fluctuations and is considered to be riskier than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ABBV vs. ABT - Financials Comparison
This section allows you to compare key financial metrics between AbbVie Inc. and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ABBV vs. ABT - Profitability Comparison
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.
ABT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a gross profit of 5.89B and revenue of 10.36B. Therefore, the gross margin over that period was 56.9%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
ABT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported an operating income of 1.69B and revenue of 10.36B, resulting in an operating margin of 16.3%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.
ABT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a net income of 1.33B and revenue of 10.36B, resulting in a net margin of 12.8%.